Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Class II fructose-bisphosphate aldolase is an enzyme found predominantly in bacteria, fungi, and some protists, where it catalyzes a key glycolytic and gluconeogenic step—the reversible cleavage of fructose 1,6-bisphosphate into dihydroxyacetone phosphate and glyceraldehyde 3-phosphate[1][3][5][7]. Unlike class I aldolases (common in animals and plants), class II aldolases require a divalent metal ion, typically zinc, for catalysis, enabling polarization of the substrate carbonyl group[1][3][5]. The enzyme adopts a TIM barrel (α/β)_8 fold and features a bimetallic active site architecture[1]. Class II aldolase is of interest as a drug target in infectious diseases because it is absent in mammals; selective inhibitors (especially metal chelators) have been explored to block metabolic pathways in pathogens without affecting the host[6]. No widely used clinical inhibitors exist yet, but research focuses on such molecules for the treatment of bacterial, fungal, and protozoal infections[6].
Inhibition by metal chelation (blocking divalent cation, usually zinc, required for enzymatic activity); Substrate analogs (competitive binding to active site)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Class II fructose-bisphosphate aldolase.